Scil Proteins is a biopharmaceutical company whose key value driver is its proprietary
Affilin® drug discovery platform. Scil Proteins has longstanding expertise in protein manufacturing, and their certified
GMP production facility generates revenue through long-term customer contracts.
15.05.2012:
Scil Proteins today announced that
it has signed a collaboration agreement with Ono Pharmaceutical Co., Ltd. (Osaka,
Japan), for the joint discovery and development of new Affilin®
therapeutics to treat various diseases. Read more...
18.04.2012:
Scil Proteins Presents the Analysis of
Folding Intermediates for Protein Production at BioProcess International
Conference in Prague
. Read more...
